DESVENLAFAXINE MEDIS desvenlafaxine 100mg modified release tablets blister

Country: Awstralja

Lingwa: Ingliż

Sors: Department of Health (Therapeutic Goods Administration)

Ingredjent attiv:

desvenlafaxine, Quantity: 100 mg

Disponibbli minn:

Medis Pharma Pty Ltd

INN (Isem Internazzjonali):

Desvenlafaxine

Għamla farmaċewtika:

Tablet, modified release

Kompożizzjoni:

Excipient Ingredients: magnesium stearate; hypromellose; alginic acid; citric acid monohydrate; povidone; purified talc; microcrystalline cellulose; titanium dioxide; macrogol 8000; iron oxide red; iron oxide black

Rotta amministrattiva:

Oral

Unitajiet fil-pakkett:

28, 7, 14

Tip ta 'preskrizzjoni:

(S4) Prescription Only Medicine

Indikazzjonijiet terapewtiċi:

For the treatment of major depressive disorder, including the preventiton of relapse. Not indicated for paediatric use.

Sommarju tal-prodott:

Visual Identification: Dark brown to red colored, diamond shaped, biconvex tablets, debossed with 'Ll90' on one side and plain on other side.; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 4 Years; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

L-istatus ta 'awtorizzazzjoni:

Licence status A

Data ta 'l-awtorizzazzjoni:

2014-11-26